United Therapeutics (UTHR) EBIT Margin (2009 - 2026)
United Therapeutics (UTHR) posted EBIT Margin of 41.69% for Q1 2026, down 7.65% sequentially from 45.14% in Q4 2025, and down 650.0% YoY from 7.58% in Q1 2025.
United Therapeutics (UTHR) EBIT Margin (2009 - 2026) Analysis & Trends
United Therapeutics has reported EBIT Margin for 18 years, with the latest figure at 41.69% in Q1 2026.
- Quarterly EBIT Margin fell 650.0% year-over-year to 41.69% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 45.29% (down 159.0% YoY) and the FY2025 annual result came in at 46.89%, down 96.0% from the prior year.
- EBIT Margin retreated to 41.69% in Q1 2026 per UTHR's latest filing, from 45.14% in the prior quarter.
- Over five years, EBIT Margin peaked at 62.35% in Q1 2022 and troughed at 35.73% in Q4 2022.
- A 5-year average of 48.7% and a median of 48.19% in 2025 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2022 and 2024: EBIT Margin jumped 7944 bps in 2022, then sank 785 bps in 2024.
- Over 5 years, EBIT Margin stood at 35.73% in 2022, then rose by 18 bps to 42.31% in 2023, then gained by 15 bps to 48.61% in 2024, then decreased by 7 bps to 45.14% in 2025, then dropped by 8 bps to 41.69% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 41.69%, 45.14%, and 48.59% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 3.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.23% |
| Mar 31, 2026 | 41.69% |
| Dec 31, 2025 | 45.14% |
| Sep 30, 2025 | 48.59% |
| Jun 30, 2025 | 45.64% |
| Mar 31, 2025 | 48.19% |
| Dec 31, 2024 | 48.61% |
| Sep 30, 2024 | 45.81% |
| Jun 30, 2024 | 44.75% |
| Mar 31, 2024 | 52.57% |
| Dec 31, 2023 | 42.31% |
| Sep 30, 2023 | 53.66% |
| Jun 30, 2023 | 52.54% |
| Mar 31, 2023 | 56.11% |
| Dec 31, 2022 | 35.73% |
| Sep 30, 2022 | 60.91% |
| Jun 30, 2022 | 43.22% |
| Mar 31, 2022 | 62.35% |
| Dec 31, 2021 | 40.90% |
| Sep 30, 2021 | 51.43% |